• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Brain and Mind Research Institute, Weill Cornell Medicine, Cornell University, New York, NY

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

An Interim Analysis of Efficacy and Safety Data in Black and Hispanic Patients With Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial

Author:Bernitsas, Evanthia   Reder, Anthony   Chinea, Angel   Herrman, Craig   O'Brien, Barbara   Sater, Richard   Amezcua, Lilyana   Williams, Mitzi   Wu, Gregory   Vartanian, Timothy   Pei, Jinglan   Acosta, Juan   Monson, Nancy   

Session Name:S31: MS Clinical Decision Making and Special Populations  

Topic:MS and Inflammatory Disease  

Program Number:S31.006  

Author Institution:Wayne State University School of Medicine, Detroit, MI  University of Chicago Medicine, Oak Park, IL  San Juan MS Center, San Juan, PR  JWM Neurology, Indianapolis, IN  Baptist Memorial Hospital-Collierville, Collierville, TN  Cone Health Medical Group, Greensboro, NC  Keck School of Medicine, University of Southern California, Los Angeles, CA  Joi Life Wellness MS Center, Smyrna, GA  Washington University in St Louis, St Louis, MO  Brain and Mind Research Institute, Weill Cornell Medicine, Cornell University, New York, NY  Genentech, Inc., South San Francisco, CA  University of Texas Southwestern, Dallas, TX  

  • View Abstract
  • View Disclosure

Effect of RIPK1 Inhibitor, SAR443820, on Serum Neurofilament Light Levels in Patients with Multiple Sclerosis: A Phase 2 Trial Design

Author:Montalban, Xavier   Kuhle, Jens   Fox, Robert   Vartanian, Timothy   Horakova, Dana   Filippi, Massimo   Roos, Ernest   Wallstroem, Erik   Atassi, Nazem   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.011  

Author Institution:Multiple Sclerosis Centre of Catalonia, Department of Neurology–Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain  Department of Neurology, University Hospital and University of Basel, Basel, Switzerland  Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH  Brain and Mind Research Institute, Weill Cornell Medicine, Cornell University, New York, NY  Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic  Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy  Sanofi, Bridgewater, NJ  Sanofi, Cambridge, MA  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com